1. At FDA, strong drug ties and less monitoring. NY Times, December 6, 2004.
2. Q&A: How best to monitor drugs after they're FDA-approved. Wall St J, December 20, 2004.
3. A 4th Painkiller is tied to increased heart risk. NY Times, December 21, 2004.
4. Second opinion: as drug-safety worries grow, looking overseas for solutions. Wall St J, December 31, 2004.
5. Risk of cardiovascular events and rofecoxib: cumulative meta-analysis